Revance Therapeutics (RVNC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -114,103 | -72,694 | -35,304 | -142,568 | -101,952 |
| Depreciation Amortization | -63 | -63 | -21 | 623 | 347 |
| Accounts receivable | 22,000 | 27,000 | 27,000 | -26,952 | N/A |
| Accounts payable and accrued liabilities | -1,050 | -321 | -3,736 | 1,691 | 793 |
| Other Working Capital | 28,220 | 23,136 | 19,664 | 22,717 | 17,380 |
| Other Operating Activity | -7,657 | -17,762 | -19,017 | 40,243 | 10,327 |
| Operating Cash Flow | $-72,653 | $-40,704 | $-11,414 | $-104,246 | $-73,105 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,943 | -1,459 | -1,084 | -313,370 | -3,830 |
| Purchase Of Investment | -228,568 | -164,970 | -127,357 | -6,991 | -212,197 |
| Sale Of Investment | 183,000 | 117,000 | 25,000 | 213,435 | 50,000 |
| Purchase Sale Intangibles | N/A | 0 | N/A | -100 | N/A |
| Other Investing Activity | 0 | 0 | 0 | -100 | -100 |
| Investing Cash Flow | $-48,511 | $-49,429 | $-103,441 | $-107,026 | $-166,127 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -932 | -932 |
| Common Stock Issued | 108,580 | 108,580 | 108,118 | 5,292 | 4,822 |
| Other Financing Activity | -1,750 | -1,669 | -1,250 | -2,578 | -2,272 |
| Financing Cash Flow | $106,830 | $106,911 | $106,868 | $1,782 | $1,618 |
| Beginning Cash Position | 73,986 | 73,986 | 73,986 | 283,476 | 283,476 |
| End Cash Position | 59,652 | 90,764 | 65,999 | 73,986 | 45,862 |
| Net Cash Flow | $-14,334 | $16,778 | $-7,987 | $-209,490 | $-237,614 |
| Free Cash Flow | |||||
| Operating Cash Flow | -72,653 | -40,704 | -11,414 | -104,246 | -73,105 |
| Capital Expenditure | -2,943 | -1,459 | -1,084 | -314,911 | -5,367 |
| Free Cash Flow | -75,596 | -42,163 | -12,498 | -419,157 | -78,472 |